Hive General Discourse

	Main Index Search Register Login Who's Online FAQ Links
	Main Index Search Register Login Who's Online FAQ Links

	2 Online, 0 Active		You are not logged in

This is a historical archiveThe forum is read-only. Private information has been removed. It is not possible to login.

	General Discourse

All posts Subject: MDMA and neuroprotective effect of prozac Please login to post

Xaja
(Hive Bee)
09-08-04 20:29
No 530343
MDMA and neuroprotective effect of prozac

Found this on mdma.net. Some beez might have seen it, but thought I would post it cause SWIX been on fluox for few months now and found this interesting reading, so other beez on fluox might too. smile

The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain
by
Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI.
Departamento de Farmacologia,
Facultad de Medicina,
Universidad Complutense, Madrid 28040, Spain.
Pharmacology Research Group,
School of Pharmacy, De Montfort University,
Leicester LE1 9BH.
AstraZeneca R&D Charnwood,
Bakewell Road, Loughborough LE11 5RH.
Br J Pharmacol 2001 Sep;134(1):46-57

ABSTRACT
1. It has been reported that co-administration of fluoxetine with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') prevents MDMA-induced degeneration of 5-HT nerve endings in rat brain. The mechanisms involved have now been investigated. 2. MDMA (15 mg kg(-1), i.p.) administration produced a neurotoxic loss of 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in cortex, hippocampus and striatum and a reduction in cortical [3H]-paroxetine binding 7 days later. 3. Fluoxetine (10 mg kg(-1), i.p., x2, 60 min apart) administered concurrently with MDMA or given 2 and 4 days earlier provided complete protection, and significant protection when given 7 days earlier. Fluvoxamine (15 mg kg(-1), i.p., x2, 60 min apart) only produced neuroprotection when administered concurrently. Fluoxetine (10 mg kg(-1), x2) markedly increased the K(D) and reduced the B(max) of cortical [3H]-paroxetine binding 2 and 4 days later. The B(max) was still decreased 7 days later, but the K(D) was unchanged. [3H]-Paroxetine binding characteristics were unchanged 24 h after fluvoxamine (15 mg kg(-1), x2). 4. A significant cerebral concentration of fluoxetine plus norfluoxetine was detected over the 7 days following fluoxetine administration. The fluvoxamine concentration had decreased markedly by 24 h. 5. Pretreatment with fluoxetine (10 mg kg(-1), x2) failed to alter cerebral MDMA accumulation compared to saline pretreated controls. 6. Neither fluoxetine or fluvoxamine altered MDMA-induced acute hyperthermia. 7. These data demonstrate that fluoxetine produces long-lasting protection against MDMA-induced neurodegeneration, an effect apparently related to the presence of the drug and its active metabolite inhibiting the 5-HT transporter. Fluoxetine does not alter the metabolism of MDMA or its rate of cerebral accumulation.

***FriedPiper***

"Fuck you and the horse you rode in on"

	https://the-hive.archive.erowid.org	the-hive@erowid.org



Powered by Entropic Forces(R) 6.11.2a, © 2014, the Mhadi Army Unlimited International
Links Erowid Rhodium

	All posts		Subject: MDMA and neuroprotective effect of prozac		Please login to post


		Xaja (Hive Bee) 09-08-04 20:29 No 530343				MDMA and neuroprotective effect of prozac
						Found this on mdma.net. Some beez might have seen it, but thought I would post it cause SWIX been on fluox for few months now and found this interesting reading, so other beez on fluox might too. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain by Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI. Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, Madrid 28040, Spain. Pharmacology Research Group, School of Pharmacy, De Montfort University, Leicester LE1 9BH. AstraZeneca R&D Charnwood, Bakewell Road, Loughborough LE11 5RH. Br J Pharmacol 2001 Sep;134(1):46-57 ABSTRACT 1. It has been reported that co-administration of fluoxetine with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') prevents MDMA-induced degeneration of 5-HT nerve endings in rat brain. The mechanisms involved have now been investigated. 2. MDMA (15 mg kg(-1), i.p.) administration produced a neurotoxic loss of 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in cortex, hippocampus and striatum and a reduction in cortical [3H]-paroxetine binding 7 days later. 3. Fluoxetine (10 mg kg(-1), i.p., x2, 60 min apart) administered concurrently with MDMA or given 2 and 4 days earlier provided complete protection, and significant protection when given 7 days earlier. Fluvoxamine (15 mg kg(-1), i.p., x2, 60 min apart) only produced neuroprotection when administered concurrently. Fluoxetine (10 mg kg(-1), x2) markedly increased the K(D) and reduced the B(max) of cortical [3H]-paroxetine binding 2 and 4 days later. The B(max) was still decreased 7 days later, but the K(D) was unchanged. [3H]-Paroxetine binding characteristics were unchanged 24 h after fluvoxamine (15 mg kg(-1), x2). 4. A significant cerebral concentration of fluoxetine plus norfluoxetine was detected over the 7 days following fluoxetine administration. The fluvoxamine concentration had decreased markedly by 24 h. 5. Pretreatment with fluoxetine (10 mg kg(-1), x2) failed to alter cerebral MDMA accumulation compared to saline pretreated controls. 6. Neither fluoxetine or fluvoxamine altered MDMA-induced acute hyperthermia. 7. These data demonstrate that fluoxetine produces long-lasting protection against MDMA-induced neurodegeneration, an effect apparently related to the presence of the drug and its active metabolite inhibiting the 5-HT transporter. Fluoxetine does not alter the metabolism of MDMA or its rate of cerebral accumulation. *FriedPiper* "Fuck you and the horse you rode in on"

	All posts		End of thread